{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:23:01Z","timestamp":1774437781253,"version":"3.50.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.2215\/cjn.07730814","type":"journal-article","created":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T07:58:15Z","timestamp":1424937495000},"page":"791-799","source":"Crossref","is-referenced-by-count":83,"title":["The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis"],"prefix":"10.2215","volume":"10","author":[{"given":"Patrick S.","family":"Parfrey","sequence":"first","affiliation":[]},{"given":"Tilman B.","family":"Dr\u00fceke","sequence":"additional","affiliation":[]},{"given":"Geoffrey A.","family":"Block","sequence":"additional","affiliation":[]},{"given":"Ricardo","family":"Correa-Rotter","sequence":"additional","affiliation":[]},{"given":"J\u00fcrgen","family":"Floege","sequence":"additional","affiliation":[]},{"given":"Charles A.","family":"Herzog","sequence":"additional","affiliation":[]},{"given":"Gerard M.","family":"London","sequence":"additional","affiliation":[]},{"given":"Kenneth W.","family":"Mahaffey","sequence":"additional","affiliation":[]},{"given":"Sharon M.","family":"Moe","sequence":"additional","affiliation":[]},{"given":"David C.","family":"Wheeler","sequence":"additional","affiliation":[]},{"given":"Yumi","family":"Kubo","sequence":"additional","affiliation":[]},{"given":"Bastian","family":"Dehmel","sequence":"additional","affiliation":[]},{"given":"William G.","family":"Goodman","sequence":"additional","affiliation":[]},{"given":"Glenn M.","family":"Chertow","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-11-20230601","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2004030203","article-title":"Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999.","volume":"16","author":"Foley","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R2-11-20230601","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease.","volume":"32","author":"Foley","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"R4-11-20230601","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality.","volume":"18","author":"London","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R5-11-20230601","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/kisup.2013.92","article-title":"Mechanisms of arterial calcifications and consequences for cardiovascular function.","volume":"3","author":"London","year":"2013","journal-title":"Kidney Int Suppl (2011"},{"key":"R6-11-20230601","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ki.2012.69","article-title":"Calcium-sensing receptor, calcimimetics, and cardiovascular calcifications in chronic kidney disease.","volume":"82","author":"Torres","year":"2012","journal-title":"Kidney Int"},{"key":"R7-11-20230601","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"R8-11-20230601","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2008.10.043","article-title":"The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE-\/-) mice.","volume":"205","author":"Ivanovski","year":"2009","journal-title":"Atherosclerosis"},{"key":"R9-11-20230601","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/ki.2008.490","article-title":"A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia.","volume":"75","author":"Koleganova","year":"2009","journal-title":"Kidney Int"},{"key":"R10-11-20230601","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/cvr\/cvt249","article-title":"Calcimimetics increase CaSR expression and reduce mineralization in vascular smooth muscle cells: Mechanisms of action.","volume":"101","author":"H\u00e9naut","year":"2014","journal-title":"Cardiovasc Res"},{"key":"R11-11-20230601","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/ndt\/gfq725","article-title":"The ADVANCE study: A randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis.","volume":"26","author":"Raggi","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R12-11-20230601","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.","volume":"367","author":"Chertow","year":"2012","journal-title":"N Engl J Med"},{"key":"R13-11-20230601","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1210\/jc.2013-2975","article-title":"The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: The EVOLVE trial.","volume":"98","author":"Parfrey","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R14-11-20230601","doi-asserted-by":"crossref","first-page":"898","DOI":"10.2215\/CJN.04381206","article-title":"Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview.","volume":"2","author":"Chertow","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R15-11-20230601","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1093\/ndt\/gfr777","article-title":"Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial.","volume":"27","author":"Chertow","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R16-11-20230601","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s11906-012-0265-8","article-title":"Vascular calcification: Pathophysiology and risk factors.","volume":"14","author":"Chen","year":"2012","journal-title":"Curr Hypertens Rep"},{"key":"R17-11-20230601","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/ndt\/15.2.218","article-title":"Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure.","volume":"15","author":"Schwarz","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"R18-11-20230601","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2215\/CJN.01760506","article-title":"Calcification of coronary intima and media: Immunohistochemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patients.","volume":"2","author":"Gross","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R19-11-20230601","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2215\/CJN.06490711","article-title":"The risk for medial arterial calcification in CKD.","volume":"7","author":"Hassan","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R20-11-20230601","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/ndt\/gfn571","article-title":"Peripheral vascular calcification in long-haemodialysis patients: Associated factors and survival consequences.","volume":"24","author":"Jean","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R21-11-20230601","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1681\/ASN.2007050622","article-title":"Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD.","volume":"19","author":"London","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R22-11-20230601","doi-asserted-by":"crossref","first-page":"e1553","DOI":"10.1136\/bmj.e1553","article-title":"Credibility of claims of subgroup effects in randomised controlled trials: systematic review.","volume":"344","author":"Sun","year":"2012","journal-title":"BMJ"},{"key":"R23-11-20230601","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.ki.5002466","article-title":"Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients.","volume":"72","author":"Suki","year":"2007","journal-title":"Kidney Int"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01277230-201505000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T21:13:39Z","timestamp":1685654019000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01277230-201505000-00011"}},"subtitle":["The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial"],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.07730814","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}